Summary
Metseras obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said
Source: STAT
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
